Visualizing Dose–Response When the Signal to Noise Ratio Is Low: The Bronchodilatory Response in Chronic Obstructive Pulmonary Disease
Authors:
- 28 September 2012
- book chapter
- Published by Springer Nature
- p. 217-239
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- The Risks and Benefits of Indacaterol — The FDA's ReviewNew England Journal of Medicine, 2011
- Outcomes for COPD pharmacological trials: from lung function to biomarkersEuropean Respiratory Journal, 2008
- Innovative Approaches for Designing and Analyzing Adaptive Dose-Ranging TrialsJournal of Biopharmaceutical Statistics, 2007